Diagnostic Nuclear Drug Market Size, Share, Growth, and Industry Analysis, By Types (Tc-99m, F-18, Other), By Applications Covered (Oncology, Cardiology, Other), Regional Insights and Forecast to 2033

Detailed TOC of Global Diagnostic Nuclear Drug Market Research Report 2025

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diagnostic Nuclear Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Tc-99m
1.2.3 F-18
1.2.4 Other
1.3 Market by Application
1.3.1 Global Diagnostic Nuclear Drug Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diagnostic Nuclear Drug Market Perspective (2018-2033)
2.2 Diagnostic Nuclear Drug Growth Trends by Region
2.2.1 Global Diagnostic Nuclear Drug Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Diagnostic Nuclear Drug Historic Market Size by Region (2018-2025)
2.2.3 Diagnostic Nuclear Drug Forecasted Market Size by Region (2024-2033)
2.3 Diagnostic Nuclear Drug Market Dynamics
2.3.1 Diagnostic Nuclear Drug Industry Trends
2.3.2 Diagnostic Nuclear Drug Market Drivers
2.3.3 Diagnostic Nuclear Drug Market Challenges
2.3.4 Diagnostic Nuclear Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diagnostic Nuclear Drug Players by Revenue
3.1.1 Global Top Diagnostic Nuclear Drug Players by Revenue (2018-2025)
3.1.2 Global Diagnostic Nuclear Drug Revenue Market Share by Players (2018-2025)
3.2 Global Diagnostic Nuclear Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Diagnostic Nuclear Drug Revenue
3.4 Global Diagnostic Nuclear Drug Market Concentration Ratio
3.4.1 Global Diagnostic Nuclear Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Nuclear Drug Revenue in 2022
3.5 Diagnostic Nuclear Drug Key Players Head office and Area Served
3.6 Key Players Diagnostic Nuclear Drug Product Solution and Service
3.7 Date of Enter into Diagnostic Nuclear Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diagnostic Nuclear Drug Breakdown Data by Type
4.1 Global Diagnostic Nuclear Drug Historic Market Size by Type (2018-2025)
4.2 Global Diagnostic Nuclear Drug Forecasted Market Size by Type (2024-2033)
5 Diagnostic Nuclear Drug Breakdown Data by Application
5.1 Global Diagnostic Nuclear Drug Historic Market Size by Application (2018-2025)
5.2 Global Diagnostic Nuclear Drug Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Diagnostic Nuclear Drug Market Size (2018-2033)
6.2 North America Diagnostic Nuclear Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Diagnostic Nuclear Drug Market Size by Country (2018-2025)
6.4 North America Diagnostic Nuclear Drug Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diagnostic Nuclear Drug Market Size (2018-2033)
7.2 Europe Diagnostic Nuclear Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Diagnostic Nuclear Drug Market Size by Country (2018-2025)
7.4 Europe Diagnostic Nuclear Drug Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diagnostic Nuclear Drug Market Size (2018-2033)
8.2 Asia-Pacific Diagnostic Nuclear Drug Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Diagnostic Nuclear Drug Market Size by Region (2018-2025)
8.4 Asia-Pacific Diagnostic Nuclear Drug Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diagnostic Nuclear Drug Market Size (2018-2033)
9.2 Latin America Diagnostic Nuclear Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Diagnostic Nuclear Drug Market Size by Country (2018-2025)
9.4 Latin America Diagnostic Nuclear Drug Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diagnostic Nuclear Drug Market Size (2018-2033)
10.2 Middle East & Africa Diagnostic Nuclear Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Diagnostic Nuclear Drug Market Size by Country (2018-2025)
10.4 Middle East & Africa Diagnostic Nuclear Drug Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cardinal Health
11.1.1 Cardinal Health Company Detail
11.1.2 Cardinal Health Business Overview
11.1.3 Cardinal Health Diagnostic Nuclear Drug Introduction
11.1.4 Cardinal Health Revenue in Diagnostic Nuclear Drug Business (2018-2025)
11.1.5 Cardinal Health Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Detail
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Diagnostic Nuclear Drug Introduction
11.2.4 GE Healthcare Revenue in Diagnostic Nuclear Drug Business (2018-2025)
11.2.5 GE Healthcare Recent Development
11.3 Curium Pharma
11.3.1 Curium Pharma Company Detail
11.3.2 Curium Pharma Business Overview
11.3.3 Curium Pharma Diagnostic Nuclear Drug Introduction
11.3.4 Curium Pharma Revenue in Diagnostic Nuclear Drug Business (2018-2025)
11.3.5 Curium Pharma Recent Development
11.4 Jubilant Pharma
11.4.1 Jubilant Pharma Company Detail
11.4.2 Jubilant Pharma Business Overview
11.4.3 Jubilant Pharma Diagnostic Nuclear Drug Introduction
11.4.4 Jubilant Pharma Revenue in Diagnostic Nuclear Drug Business (2018-2025)
11.4.5 Jubilant Pharma Recent Development
11.5 Bracco Imaging
11.5.1 Bracco Imaging Company Detail
11.5.2 Bracco Imaging Business Overview
11.5.3 Bracco Imaging Diagnostic Nuclear Drug Introduction
11.5.4 Bracco Imaging Revenue in Diagnostic Nuclear Drug Business (2018-2025)
11.5.5 Bracco Imaging Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Diagnostic Nuclear Drug Introduction
11.6.4 Novartis Revenue in Diagnostic Nuclear Drug Business (2018-2025)
11.6.5 Novartis Recent Development
11.7 SIEMENS
11.7.1 SIEMENS Company Detail
11.7.2 SIEMENS Business Overview
11.7.3 SIEMENS Diagnostic Nuclear Drug Introduction
11.7.4 SIEMENS Revenue in Diagnostic Nuclear Drug Business (2018-2025)
11.7.5 SIEMENS Recent Development
11.8 China Isotope & Radiation
11.8.1 China Isotope & Radiation Company Detail
11.8.2 China Isotope & Radiation Business Overview
11.8.3 China Isotope & Radiation Diagnostic Nuclear Drug Introduction
11.8.4 China Isotope & Radiation Revenue in Diagnostic Nuclear Drug Business (2018-2025)
11.8.5 China Isotope & Radiation Recent Development
11.9 Dongcheng
11.9.1 Dongcheng Company Detail
11.9.2 Dongcheng Business Overview
11.9.3 Dongcheng Diagnostic Nuclear Drug Introduction
11.9.4 Dongcheng Revenue in Diagnostic Nuclear Drug Business (2018-2025)
11.9.5 Dongcheng Recent Development
11.10 Lantheus
11.10.1 Lantheus Company Detail
11.10.2 Lantheus Business Overview
11.10.3 Lantheus Diagnostic Nuclear Drug Introduction
11.10.4 Lantheus Revenue in Diagnostic Nuclear Drug Business (2018-2025)
11.10.5 Lantheus Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Detail
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Diagnostic Nuclear Drug Introduction
11.11.4 Eli Lilly Revenue in Diagnostic Nuclear Drug Business (2018-2025)
11.11.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details